RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Return on equity (%)

VERTEX PHARMACEUTICALS INC【VRTX】

Market cap
$119.1B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-3.1-113.70%
Dec 31, 202323-16.91%
Dec 31, 202227.7+10.99%
Dec 31, 202124.9-32.09%
Dec 31, 202036.7+64.10%
Dec 31, 201922.4-65.45%
Dec 31, 201864.7+315.27%
Dec 31, 201715.6-325.62%
Dec 31, 2016-6.9-86.40%
Dec 31, 2015-50.8-15.64%
Dec 31, 2014-60.2+72.73%
Dec 31, 2013-34.9+624.95%
Dec 31, 2012-4.8-183.65%
Dec 31, 20115.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)